Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection

Michelle A. Kendall, Umesh Lalloo, Courtney V. Fletcher, Xingye Wu, Anthony T. Podany, Sandra W. Cardoso, Prudence Ive, Constance A. Benson

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection'. Together they form a unique fingerprint.

Medicine & Life Sciences